NCT06790420Completed
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
To evaluate the incidence of the outcomes for the safety specifications in patients of Medical Data Vision database in Japan diagnosed with CD20 positive B-cell non- Hodgkin's lymphoma who were treated with Rituximab Pfizer to compare it with outcomes in patients who were treated with Rituxan from 01 January 2020 through 31 December 2024
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2703 (actual)
- First submitted
- 9 Jan 2025
- Start date
- 31 Jan 2025
- Primary completion date
- 14 Mar 2025
- Lead sponsor
- Pfizer
- Diseases
- Childhood cancers
- NCT number
- NCT06790420
What you commit to
- Study type: Observational
- Participants enrolled: 2703
- From 31 Jan 2025 to the primary completion date, 14 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\. Have any diagnosis of other indications of rituximab products other than CD20 positive B-cell non- Hodgkin's lymphoma before index date .
Who the study is looking for
- Have prescription of Rituximab Pfizer or Rituxan within the enrollment period (Index Date: first prescription date within the enrollment period).
- Have diagnosis of CD20 positive B-cell non- Hodgkin's lymphoma on the index month or within 6 months before index date
- Have at least 6 months of Look back period and at least one medical record prior to 7 months before the Index date.
- Have not prescription of Rituximab product before index date(Comparative Analysis Set only).
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.